Diabetes
Conditions
Keywords
insulin infusion, continuous glucose sensor
Brief summary
To determine the performance of the Dexcom CGM device in comparison to arterial glucose samples.
Detailed description
The performance of the Dexcom continuous glucose sensor will be compared with the current standard of care which is arterial glucose samples analyzed on a glucose meter. Subjects will be ICU patients receiving intravenous insulin infusions.
Interventions
Continuous glucose sensor results will be compared with arterial glucose samples
Sponsors
DexCom, Inc.
University of British Columbia
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* minimum age 18 years * anticipated to be on an insulin infusion for 3-7 consecutive days * 10 of these subjects will be on vasopressors who will be receiving large volume fluid resuscitation
Exclusion criteria
* subjects not on insulin infusion
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Continous Glucose Sensor values (CGM) | 3 to 7 consecutive days | CGM will be compared with arterial glucose values |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Vasopressor Use | 3 to 7 consecutive days | 10 of the 20 subjects will be on vasopressors and large volume fluid resuscitation |
Countries
Canada
Contacts
Primary ContactDavid M Thompson, MD
Backup ContactBarbara J Allan, MHA
Outcome results
None listed